EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

OPA1 as a Cancer Target: Molecular Mechanisms, Structural Insights, and Strategies for Drug Development

Antonio Curcio iD, Ludovica Ganino, Ilenia Valentino, Massimo Gentile, Stefano Alcaro iD, Roberta Rocca iD, Anna Artese iD, Nicola Amodio

Antioxidants · 22.01.2026 · 15 (1) · 144

DOI: 10.3390/antiox15010144 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Antioxidants, online erschienen am 22.01.2026. Verfasst von Antonio Curcio und 7 weiteren Autor:innen. Beteiligte Einrichtung: Dipartimento di Scienze della Salute, Università Magna Græcia, 88100 Catanzaro, Italy. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Associazione Italiana per la Ricerca sul Cancro, PRIN PNRR 2022, Italian Association for Cancer Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mitochondria are highly dynamic organelles that integrate metabolic regulation, signal transduction, and programmed cell death with their canonical role in adenosine triphosphate (ATP) production. Their ability to undergo continuous remodeling through the opposing processes of fusion and fission is essential for maintaining cellular homeostasis, preserving organelle quality control, and enabling adaptive responses to metabolic and oxidative stress. Among the core regulators of mitochondrial dynamics, the dynamin-related guanosine triphosphatase (GTPase) OPA1 plays a central role in inner membrane fusion, cristae architecture maintenance, bioenergetic efficiency, and the modulation of redox balance and apoptotic signaling. Accumulating evidence indicates that dysregulation of OPA1 expression or activity contributes to the initiation and progression of multiple malignancies, underscoring its importance in tumor cell survival, proliferation, metabolic adaptation, and resistance to stress. Here, we summarize current knowledge on OPA1 dysregulation in cancer and, based on preliminary, unpublished in silico analyses, we highlight the growing relevance of OPA1 as a therapeutic target, particularly through its GTPase domain and the still understudied Interface 7. Overall, these findings outline how integrated computational approaches could potentially guide the identification of novel OPA1 modulators, offering a conceptual framework that highlights OPA1 as a promising, yet still largely underexplored, target in oncology.

Schlagwörter

Stichwörter der Autor:innen

OPA1SBVSdockingmitochondriamitochondrial dynamicsmitochondrial dysfunction

Autor:innen und Institutionen

  • Dipartimento di Scienze della Salute, Università Magna Græcia, 88100 Catanzaro, Italy.
  • Dipartimento di Medicina Sperimentale e Clinica, Università Magna Græcia, 88100 Catanzaro, Italy.
  • Hematology Unit, Azienda Ospedaliera Annunziata, 87100 Cosenza, Italy.
  • Department of Pharmacy, Health and Nutritional Science, University of Calabria, 87036 Rende, Italy.
  • Associazione CRISEA-Centro di Ricerca e Servizi Avanzati per l'Innovazione Rurale, Località Condoleo di Belcastro, 88055 Catanzaro, Italy.

ORCID-Profile: Antonio Curcio, Stefano Alcaro, Roberta Rocca, Anna Artese

Förderung

  • Associazione Italiana per la Ricerca sul Cancro
  • PRIN PNRR 2022
  • Italian Association for Cancer Research

Zitieren

APA

Curcio, A., Ganino, L., Valentino, I., Gentile, M., Alcaro, S., Rocca, R., Artese, A., & Amodio, N. (2026). OPA1 as a Cancer Target: Molecular Mechanisms, Structural Insights, and Strategies for Drug Development. Antioxidants, 15(1), 144. https://doi.org/10.3390/antiox15010144

Vancouver

Curcio A, Ganino L, Valentino I, Gentile M, Alcaro S, Rocca R, et al. OPA1 as a Cancer Target: Molecular Mechanisms, Structural Insights, and Strategies for Drug Development. Antioxidants. 2026;15(1):144. doi:10.3390/antiox15010144

BibTeX
@article{Curcio2026,
  author = {Curcio, Antonio and Ganino, Ludovica and Valentino, Ilenia and Gentile, Massimo and Alcaro, Stefano and Rocca, Roberta and Artese, Anna and Amodio, Nicola},
  title = {OPA1 as a Cancer Target: Molecular Mechanisms, Structural Insights, and Strategies for Drug Development},
  journal = {Antioxidants},
  year = {2026},
  volume = {15},
  number = {1},
  pages = {144},
  doi = {10.3390/antiox15010144}
}
Kostenlos starten →